Last viewed:
TEVJF
Prices are updated after-hours
TEVJF
|
News
|
$8.34
0.48%
|
|
Health Technology
(0.0% 1d)
(-8.8% 1m)
(-15.1% 1y)
(0.0% 2d)
(0.5% 3d)
(0.5% 7d)
(-34.1%
volume)
Earnings Calendar:
http://www.teva.co.il
Sec
Filling
|
Patents
| n/a employees
(IL) Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.
cancer
infectious disease
pain relief
israel
add to watch list
email alert is off
Price chart
% (High / Open) change chart
Press-releases
Interstitial Cystitis Drugs Market Recorded 4.81% Y-O-Y Growth Rate in 2021| Evolving Opportunities with Perrigo Co. Plc & Pfizer Inc | Technavio
Published: 2022-06-29
(Just crawled : 09:00)
- prnewswire.com
ALPMY
|
News
|
$16.14
1.19%
|
|
Manufacturing
| Email alert
Add to watchlist
NVSEF
|
News
|
$84.85
1.0%
|
|
Health Technology
| Email alert
Add to watchlist
VTRS
|
News
|
$10.9
-1.54%
1.19%
|
|
Health Technology
| Email alert
Add to watchlist
ALPMF
|
News
|
$16.71
5.56%
|
|
Health Technology
| Email alert
Add to watchlist
NVS
|
News
|
$84.17
-1.3%
0.12%
|
|
Health Technology
| Email alert
Add to watchlist
TEVJF
|
News
|
$8.34
0.48%
|
|
Health Technology
| Email alert
Add to watchlist
growth
market
Herpes Treatment Market size to grow by USD 723.04 Mn | Market Research Insights highlight increasing prevalence of herpes infection as Key Driver | Technavio
Published: 2022-06-29
(Crawled : 04:00)
- prnewswire.com
BHC
|
News
A
|
$8.83
1.73%
-0.57%
|
|
Health Technology
| Email alert
Add to watchlist
VTRS
|
News
|
$10.9
-1.54%
1.19%
|
|
Health Technology
| Email alert
Add to watchlist
NVS
|
News
|
$84.17
-1.3%
0.12%
|
|
Health Technology
| Email alert
Add to watchlist
GLAXF
|
News
|
$21.99
4.22%
|
|
Health Technology
| Email alert
Add to watchlist
TEVJF
|
News
|
$8.34
0.48%
|
|
Health Technology
| Email alert
Add to watchlist
GSK
|
News
|
$43.35
-0.8%
-0.09%
|
|
Health Technology
| Email alert
Add to watchlist
NVSEF
|
News
|
$84.85
1.0%
|
|
Health Technology
| Email alert
Add to watchlist
treatment
research
infection
market
Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
Published: 2022-06-27
(Crawled : 12:20)
- prnewswire.com
BMY
|
$78.7
-1.6%
1.19%
|
|
Health Technology
| 0.1%
| O: 0.78%
H: 1.72%
C: 0.95%
BAX
|
$65.25
-2.19%
0.0%
|
|
Health Technology
| 2.02%
| O: 4.39%
H: 0.97%
C: -0.09%
BMRN
|
$83.15
-2.28%
-1.6%
|
|
Health Technology
| -2.54%
| O: 1.23%
H: 0.57%
C: -1.48%
NVO
|
News
|
$108.3
-4.07%
-0.18%
|
|
Health Technology
| -3.14%
| O: 0.72%
H: 0.0%
C: 0.0%
KMDA
|
$4.48
-0.44%
0.0%
|
|
Health Technology
| -2.82%
| O: -1.52%
H: 0.67%
C: -0.88%
ABEO
|
$0.1842
0.6%
1.79%
|
|
Health Technology
| 0.11%
| O: -5.43%
H: 9.2%
C: 5.23%
care
for
therapeutics
growth
Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-06-24
(Crawled : 21:00)
- prnewswire.com
ENDP
|
$0.71
85.33%
2.54%
|
|
Health Technology
| Email alert
Add to watchlist
SNYNF
|
News
|
$108.84
4.15%
|
|
Health Technology
| Email alert
Add to watchlist
MNKKQ
|
$0.02
|
|
Manufacturing
| Email alert
Add to watchlist
AZN
|
$65.93
-0.87%
0.12%
|
|
Health Technology
| Email alert
Add to watchlist
PFE
|
News
|
$50.66
-2.35%
0.08%
|
|
Health Technology
| Email alert
Add to watchlist
AZNCF
|
$131.7
3.5%
|
|
Health Technology
| Email alert
Add to watchlist
MNK
|
$
0%
|
|
n/a
| Email alert
Add to watchlist
SNY
|
News
|
$52.14
-0.88%
-0.38%
|
|
Health Technology
| Email alert
Add to watchlist
TEVJF
|
News
|
$8.34
0.48%
|
|
Health Technology
| Email alert
Add to watchlist
trends
report
market
Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis Demonstrating that Deep Serum TTR Reductions Remained Durable After a Single Dose
Published: 2022-06-24
(Crawled : 12:00)
- globenewswire.com
SNY
|
News
|
$52.14
-0.88%
-0.38%
|
|
Health Technology
| 2.92%
| O: 3.49%
H: 0.0%
C: 0.0%
REGN
|
$594.42
-1.33%
0.0%
|
|
Health Technology
| 0.11%
| O: 3.08%
H: 0.18%
C: 0.07%
NTLA
|
$52.03
-2.57%
-1.83%
|
|
Health Technology
| 12.3%
| O: 13.34%
H: 5.18%
C: 1.71%
ntla-2001
treatment
for
Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based NTLA-2001 for the Treatment of Transthyretin (ATTR)
Published: 2022-06-24
(Crawled : 12:00)
- biospace.com/
NTLA
|
$52.03
-2.57%
-1.83%
|
|
Health Technology
| 12.3%
| O: 13.34%
H: 5.18%
C: 1.71%
REGN
|
$594.42
-1.33%
0.0%
|
|
Health Technology
| 0.11%
| O: 3.08%
H: 0.18%
C: 0.07%
SNY
|
News
|
$52.14
-0.88%
-0.38%
|
|
Health Technology
| 2.92%
| O: 3.49%
H: 0.0%
C: 0.0%
ntla-2001
treatment
for
Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)
Published: 2022-06-24
(Crawled : 20:00)
- biospace.com/
TEVJF
|
News
|
$8.34
0.48%
|
|
Health Technology
| Email alert
Add to watchlist
ajovy
results
Contraceptives Drugs Market Size Will Observe Substantial Growth by 2030 Wilmington, Delaware, United States: Childbearing at an early age has become an issue of concern and to prevent the deaths cause...
Published: 2022-06-23
(Crawled : 06:00)
- biospace.com/
SNY
|
News
|
$52.14
-0.88%
-0.38%
|
|
Health Technology
| 4.83%
| O: 1.85%
H: 0.0%
C: 0.0%
JNJ
|
News
|
$176.94
-2.84%
0.03%
|
|
Health Technology
| 2.84%
| O: 2.76%
H: 0.0%
C: 0.0%
GLAXF
|
News
|
$21.99
4.22%
|
|
Health Technology
| 2.33%
| O: -0.14%
H: 0.14%
C: -2.96%
GSK
|
News
|
$43.35
-0.8%
-0.09%
|
|
Health Technology
| 3.76%
| O: 1.24%
H: 0.0%
C: 0.0%
contraceptives
growth
market
Alvotech Debuts on NASDAQ First North Growth Market Becoming First Dual-Listed Icelandic Company in United States and Iceland
Published: 2022-06-22
(Crawled : 23:00)
- globenewswire.com
ALVO
|
$8.98
-1.97%
0.0%
|
|
n/a
| -6.36%
| O: 14.7%
H: 7.25%
C: -18.18%
KMDA
|
$4.48
-0.44%
0.0%
|
|
Health Technology
| -2.4%
| O: -0.44%
H: 0.0%
C: -1.53%
nasdaq
growth
market
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market to Surpass US$ 20,450.6 Million by 2030 - Coherent Market Insights
Published: 2022-06-22
(Crawled : 19:00)
- prnewswire.com
ABBV
|
News
|
$152.49
-0.42%
-0.06%
|
|
Health Technology
| 3.34%
| O: 0.57%
H: 0.0%
C: 0.0%
GSK
|
News
|
$43.35
-0.8%
-0.09%
|
|
Health Technology
| 3.76%
| O: 1.24%
H: 0.0%
C: 0.0%
ENDP
|
$0.71
85.33%
2.54%
|
|
Health Technology
| 97.22%
| O: -2.25%
H: 13.16%
C: 10.83%
GLAXF
|
News
|
$21.99
4.22%
|
|
Health Technology
| 2.33%
| O: -0.14%
H: 0.14%
C: -2.96%
PFE
|
News
|
$50.66
-2.35%
0.08%
|
|
Health Technology
| 5.58%
| O: 0.43%
H: 0.0%
C: 0.0%
infections
skin
market
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001209191-22-030308
4
2022-05-19
2022-05-17
Sell
S
130000
1387